Letter from the Editor EditorProf. Hans-Peter Hartung , Heinrich Heine University, Düsseldorf, Germany ConferenceAAN 2023 26 June, 2023 19:19
AAN 2023 Highlights Podcast Presented ByRobert van den Heuvel, Medicom ConferenceAAN 2023 14 May, 2023 19:44
Positive results for hereditary transthyretin-mediated amyloid polyneuropathy ExpertProf. Sami Khella, University of Pennsylvania, PA, USA TrialPhase 3, NEURO-TTRansform ConferenceAAN 2023 26 April, 2023 14:01
Original antigenic sin influences humoral immune response to SARS-CoV-2 ConferenceAAN 2023 26 June, 2023 19:36
Allogenic T-cell-based immunotherapy for PML in development Presented ByDr George Ambalathingal, QIMR Berghofer Medical Research Institute, Australia TrialPhase 2, CE-VST01-JC ConferenceAAN 2023 26 June, 2023 19:32
Lecanemab may slow decline of cognition and function in Alzheimer’s Disease Presented ByProf. Christopher van Dyck, Yale School of Medicine, CT, USA TrialPhase 3, CLARITY AD ConferenceAAN 2023 26 June, 2023 19:44
Donanemab shows rapid and deep plaque clearance in early Alzheimer’s Disease Presented ByProf. Stephen Salloway, Warren Alpert Medical School of Brown University, RI, USA TrialPhase 3, TRAILBLAZER-ALZ 4 ConferenceAAN 2023 26 June, 2023 19:38
Seizure forecasting and detection with wearable devices are feasible Presented ByDr Benjamin Brinkmann, Mayo Clinic, MI, USA TrialMy Seizure Gauge ConferenceAAN 2023 26 June, 2023 19:56
Encouraging first results of GABAergic interneurons implants for focal epilepsy Presented ByProf. David Spencer, Oregon Health & Science University, OR, USA TrialPhase 1/2, NTRX-1001 GABAergic interneuron cell therapy ConferenceAAN 2023 26 June, 2023 19:50
Lecture on migraine: from the prodromal phase to future paradigm shifts Presented ByProf. Peter Goadsby, King's College London, UK ConferenceAAN 2023 26 June, 2023 20:24
Zavegepant nasal spray exhibits good efficacy and safety in acute migraine Presented ByProf. Richard Lipton, Albert Einstein College of Medicine, NY, USA TrialPhase 3 ConferenceAAN 2023 26 June, 2023 20:18
Atogepant helps prevent treatment-resistant episodic migraine TrialELEVATE ConferenceAAN 2023 26 June, 2023 20:13
Simultaneous head-to-head comparison of 25 migraine medications ConferenceAAN 2023 26 June, 2023 20:10
A vaccine as a potentially safe and effective immunotherapy against CGRP Presented ByDr Jean-Cosme Dodart, Vaxxinity Inc, FL, USA TrialPhase 1, UB-313 ConferenceAAN 2023 26 June, 2023 20:04
Transcriptome data predicts long-term outcomes in untreated PPMS patients TrialORATORIO ConferenceAAN 2023 26 June, 2023 20:42
Teriflunomide prevents conversion to MS in patients with RIS Presented ByProf. Christine Lebrun-Frenay, Centre Hospitalier Universitaire de Nice, France TrialPhase 3, TERIS ConferenceAAN 2023 26 June, 2023 20:39
Positive 4-year efficacy and safety data of ocrelizumab in early MS TrialPhase 3, ENSEMBLE ConferenceAAN 2023 26 June, 2023 20:36
Gold nanocrystals may be effective as adjunctive MS therapy Presented ByProf. Michael Barnett, University of Sydney, Australia TrialPhase 2, VISIONARY-MS ConferenceAAN 2023 26 June, 2023 20:33
Stem cell therapy fails primary endpoint but improves walking in more advanced progressive MS TrialPhase 2 ConferenceAAN 2023 26 June, 2023 20:30
Ravulizumab effective in AQP4+ NMOSD Presented ByDr Sean Pittock, Mayo Clinic, NY, USA TrialPhase 3, CHAMPION-NMOSD ConferenceAAN 2023 26 June, 2023 20:28
First-ever ALS platform trial reports on outcomes of 4 treatments Presented ByProf. Sabrina Paganoni, Massachusetts General Hospital, MA, USA TrialHEALEY ALS Platform Trial ConferenceAAN 2023 26 June, 2023 20:49
Pridopidine for Huntington’s disease fails to meet the primary endpoint Presented ByProf. Andrew Feigin, NYU Grossman School of Medicine, NY, USA TrialPhase 3, PROOF-HD ConferenceAAN 2023 26 June, 2023 20:46
Continuous levodopa/carbidopa infusion shows favourable safety and efficacy Presented ByDr Aaron Ellenbogen, Michigan Institute for Neurological Disorders, MI, USA TrialPhase 2, BeyoND ConferenceAAN 2023 26 June, 2023 20:54
Unilateral right STN-DBS improves verbal fluency Presented ByDr Victor del Bene, University of Alabama, AL, USA TrialSUNDIAL ConferenceAAN 2023 26 June, 2023 20:52
Harnessing the microbiome as a possible stroke treatment Presented ByProf. Louise McCullough, University of Texas Health Science Center, TX, USA ConferenceAAN 2023 26 June, 2023 21:00
Patients with a large core infarct benefit from thrombectomy Presented ByDr Amrou Sarraj, UH Cleveland Medical Center, OH, USA TrialPhase 3, SELECT2 ConferenceAAN 2023 26 June, 2023 20:57
Artificial intelligence applications in neurology: seize the moment Presented ByProf. Kathryn Davis, Penn Medicine, PA, USA ConferenceAAN 2023 26 June, 2023 21:10
Spinal cord stimulation eases painful diabetic neuropathy Presented ByDr Erika Petersen, University of Arkansas, AR, USA TrialSENZA-PDN ConferenceAAN 2023 26 June, 2023 21:08
EVT improves functional outcomes in Chinese patients with BAO Presented ByProf. Raul Nogueira, Grady Memorial Hospital, GA, USA TrialATTENTION ConferenceAAN 2023 26 June, 2023 21:05
Severe sleep apnoea associated with white matter hyperintensities Presented ByDr Diego Carvalho, Mayo Clinic, MN, USA ConferenceAAN 2023 26 June, 2023 21:03